{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:29:52Z","timestamp":1791635392579,"version":"4.3.4"},"reference-count":130,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2010,6,17]],"date-time":"2010-06-17T00:00:00Z","timestamp":1276732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Migraine is a common disabling neurological disorder with a serious socio-economical burden. By blocking cyclooxygenase nonsteroidal anti-inflammatory drugs (NSAIDs) decrease the synthesis of prostaglandins, which are involved in the pathophysiology of migraine headaches. Despite the introduction more than a decade ago of a new class of migraine-specific drugs with superior efficacy, the triptans, NSAIDs remain the most commonly used therapies for the migraine attack. This is in part due to their wide availability as over-the-counter drugs and their pharmaco-economic advantages, but also to a favorable efficacy\/side effect profile at least in attacks of mild and moderate intensity. We summarize here both the experimental data showing that NSAIDs are able to influence several pathophysiological facets of the migraine headache and the clinical studies providing evidence for the therapeutic efficacy of various subclasses of NSAIDs in migraine therapy. Taken together these data indicate that there are several targets for NSAIDs in migraine pathophysiology and that on the spectrum of clinical potency acetaminophen is at the lower end while ibuprofen is among the most effective drugs. Acetaminophen and aspirin excluded, comparative trials between the other NSAIDs are missing. Since evidence-based criteria are scarce, the selection of an NSAID should take into account proof and degree of efficacy, rapid GI absorption, gastric ulcer risk and previous experience of each individual patient. If selected and prescribed wisely, NSAIDs are precious, safe and cost-efficient drugs for the treatment of migraine attacks.<\/jats:p>","DOI":"10.3390\/ph3061966","type":"journal-article","created":{"date-parts":[[2010,6,17]],"date-time":"2010-06-17T11:12:43Z","timestamp":1276773163000},"page":"1966-1987","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["NSAIDs in the Acute Treatment of Migraine: A Review of Clinical and Experimental Data"],"prefix":"10.3390","volume":"3","author":[{"given":"Arpad","family":"Pardutz","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Szeged, Semmelweis u. 6. Szeged, Hungary H-6720, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Schoenen","sequence":"additional","affiliation":[{"name":"Headache Research Unit, Department of Neurology & GIGA Neurosciences, Li\u00e8ge University, CHU-Sart Tilman, T4(+1), B36, B-4000 Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2010,6,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00482-007-0619-3","article-title":"Current diagnosis and treatment of migraine","volume":"22","author":"Diener","year":"2008","journal-title":"Schmerz"},{"key":"ref_2","unstructured":"(2004). The international classification of headache disorders. Cephalalgia, 24, 9\u2013160."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1526-4610.2001.041007638.x","article-title":"Migraine diagnosis and treatment: Results from the American Migraine Study II","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1212\/WNL.60.3.441","article-title":"Patterns of health care utilization for migraine in England and in the United States","volume":"60","author":"Lipton","year":"2003","journal-title":"Neurology"},{"key":"ref_5","first-page":"202","article-title":"NSAIDs: Behind the mechanisms of action","volume":"15","author":"Tulunay","year":"2000","journal-title":"Funct. Neurol."},{"key":"ref_6","unstructured":"Hardman, J.G., Limbird, L.E., and Goodman Gilman, Alfred (1996). Goodman and Gilman's: The Pharmacological Basis for Therapeutics, McGraw-Hil. [9th]."},{"key":"ref_7","first-page":"18","article-title":"Effects of salicylates on human-platelets","volume":"51","author":"Obrien","year":"1980","journal-title":"CC\/Clin. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0306-4522(98)00366-2","article-title":"Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro","volume":"89","author":"Ebersberger","year":"1999","journal-title":"Neuroscience"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410230214","article-title":"Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system","volume":"23","author":"Goadsby","year":"1988","journal-title":"Ann. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jemt.1081","article-title":"Neurogenic inflammation in the context of migraine","volume":"53","author":"Williamson","year":"2001","journal-title":"Microsc. Res. Tech."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1468-2982.1988.0802083.x","article-title":"Neurogenically mediated plasma extravasation in dura mater: Effect of ergot alkaloids. A possible mechanism of action in vascular headache","volume":"8","author":"Markowitz","year":"1988","journal-title":"Cephalalgia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1468-2982.1997.1704518.x","article-title":"Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat","volume":"17","author":"Williamson","year":"1997","journal-title":"Cephalalgia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/384560a0","article-title":"Sensitization of meningeal sensory neurons and the origin of headaches","volume":"384","author":"Strassman","year":"1996","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1468-2982.1981.0103143.x","article-title":"The site of pain origin during migraine attacks","volume":"1","author":"Blau","year":"1981","journal-title":"Cephalalgia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neulet.2009.01.032","article-title":"Localization of COX-1 and COX-2 in the intracranial dura mater of the rat","volume":"452","author":"Zhang","year":"2009","journal-title":"Neurosci. Lett."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0304-3959(98)00267-X","article-title":"Acetylsalicylic acid inhibits meningeal nociception in rat","volume":"81","author":"Ellrich","year":"1999","journal-title":"Pain"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1460-9568.2008.06068.x","article-title":"Sensitization of meningeal nociceptors: Inhibition by naproxen","volume":"27","author":"Levy","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(89)90719-X","article-title":"Indomethacin and acetylsalicylic-acid block neurogenic plasma-protein extravasation in rat dura mater","volume":"165","author":"Buzzi","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1526-4610.2006.00332.x","article-title":"Effects of parecoxib on plasma protein extravasation and c-fos expression in the rat","volume":"46","author":"Tayefeh","year":"2006","journal-title":"Headache"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1152\/jn.1998.79.2.964","article-title":"Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons","volume":"79","author":"Burstein","year":"1998","journal-title":"J. Neurophysiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N","article-title":"An association between migraine and cutaneous allodynia","volume":"47","author":"Burstein","year":"2000","journal-title":"Ann. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neulet.2004.05.067","article-title":"Regulation of calcitonin gene-related peptide release from rat trigeminal nucleus caudalis slices in vitro","volume":"366","author":"Jenkins","year":"2004","journal-title":"Neurosci. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-5793(96)00604-7","article-title":"Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation","volume":"390","author":"Beiche","year":"1996","journal-title":"FEBS Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-1-4899-1810-9_45","article-title":"Cyclooxygenase-2 in the spinal cord: Localization and regulation after a peripheral inflammatory stimulus","volume":"433","author":"Beiche","year":"1997","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1526-4610.1993.hed3310541.x","article-title":"Intravenous acetylsalicylic-acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal-cord in the cat","volume":"33","author":"Kaube","year":"1993","journal-title":"Headache"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0074-7742(07)82020-4","article-title":"A role for brain cyclooxygenase-2 and prostaglandin-E2 in migraine: Effects of nitroglycerin","volume":"82","author":"Tassorelli","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0028-3908(97)00122-6","article-title":"Neurochemical mechanisms of nitroglycerin-induced neuronal activation in rat brain: A pharmacological investigation","volume":"36","author":"Tassorelli","year":"1997","journal-title":"Neuropharmacology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1468-2982.2004.00699.x","article-title":"Nitroglycerin-induced nNOS increase in rat trigeminal nucleus caudalis is inhibited by systemic administration of lysine acetylsalicylate but not of sumatriptan","volume":"24","author":"Pardutz","year":"2004","journal-title":"Cephalalgia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1526-4610.2006.00721.x","article-title":"Cox-2 inhibitor attenuates NO-induced nNOS in rat caudal trigeminal nucleus","volume":"47","author":"Varga","year":"2007","journal-title":"Headache"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2008.12.038","article-title":"Selective inhibition of cyclooxygenase-2 attenuates nitroglycerin-induced calmodulin-dependent protein kinase II alpha in rat trigeminal nucleus caudalis","volume":"451","author":"Varga","year":"2009","journal-title":"Neurosci. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pnpbp.2009.02.010","article-title":"Intracisternal administration of COX inhibitors attenuates mechanical allodynia following compression of the trigeminal ganglion in rats","volume":"33","author":"Yang","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1046\/j.1526-4610.1997.3710622.x","article-title":"Positron emission tomography studies in headache","volume":"37","author":"Diener","year":"1997","journal-title":"Headache"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1526-4610.1983.hed2306258.x","article-title":"Brainstem influences on the cephalic circulation: Experimental data from cat and monkey of relevance to the mechanism of migraine","volume":"23","author":"Lance","year":"1983","journal-title":"Headache"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nm0795-658","article-title":"Brain stem activation in spontaneous human migraine attacks","volume":"1","author":"Weiller","year":"1995","journal-title":"Nat. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/cne.903220309","article-title":"Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain","volume":"322","author":"Breder","year":"1992","journal-title":"J. Comp. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/cne.903550208","article-title":"Characterization of inducible cyclooxygenase in rat brain","volume":"355","author":"Breder","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0361-9230(02)00872-9","article-title":"Modulation of cyclooxygenase-2 on glycine- and glutamate-induced ion currents in rat periaqueductal gray neurons","volume":"59","author":"Shin","year":"2003","journal-title":"Brain Res. Bull."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.bjp.0701818","article-title":"Enhancement of opioid inhibition of GABAergic synaptic transmission by cyclo-oxygenase inhibitors in rat periaqueductal grey neurones","volume":"123","author":"Vaughan","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"11296","DOI":"10.1523\/JNEUROSCI.2586-07.2007","article-title":"Cyclooxygenase-1-derived prostaglandins in the periaqueductal gray differentially control C- vs. A-fiber-evoked spinal nociception","volume":"27","author":"Leith","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/jn.1944.7.6.359","article-title":"Spreading depression of activity in cerebral cortex","volume":"7","author":"Leao","year":"1944","journal-title":"J. Neurophysiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ana.410120510","article-title":"Persistent oligemia of rat cerebral cortex in the wake of spreading depression","volume":"12","author":"Lauritzen","year":"1982","journal-title":"Ann. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/brain\/117.1.199","article-title":"Pathophysiology of the migraine aura. The spreading depression theory","volume":"117","author":"Lauritzen","year":"1994","journal-title":"Brain"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1523\/JNEUROSCI.13-03-01167.1993","article-title":"Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms","volume":"13","author":"Moskowitz","year":"1993","journal-title":"J. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nm0202-136","article-title":"Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model","volume":"8","author":"Bolay","year":"2002","journal-title":"Nat. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000117004","article-title":"Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat","volume":"34","author":"Kaube","year":"1994","journal-title":"Eur. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF00169175","article-title":"Effects of antimigraine drugs on retinal spreading depression","volume":"353","author":"Wiedemann","year":"1996","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0006-8993(92)90469-P","article-title":"Pial arteriolar constriction following cortical spreading depression is mediated by prostanoids","volume":"572","author":"Shibata","year":"1992","journal-title":"Brain Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1023\/A:1007559003261","article-title":"Spreading depression-induced cyclooxygenase-2 expression in the cortex","volume":"25","author":"Koistinaho","year":"2000","journal-title":"Neurochem. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.94.12.6500","article-title":"Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2","volume":"94","author":"Miettinen","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.WCB.0000055293.67563.2E","article-title":"Cyclooxygenase-2 expression associated with spreading depression in a primate model","volume":"23","author":"Yokota","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1748-1716.1965.tb04187.x","article-title":"Cardiovascular and metabolic response to infusions of prostaglandin E1 and to simultaneous infusions of noradrenaline and prostaglandin E1 in man. Prostaglandin and related factors 35","volume":"64","author":"Carlson","year":"1965","journal-title":"Acta Physiol. Scand."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.0954-6820.1968.tb10502.x","article-title":"Clinical and metabolic effects of different doses of prostaglandin E1 in man. Prostaglandin and related factors","volume":"183","author":"Carlson","year":"1968","journal-title":"Acta Med. Scand."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0024-3205(79)90507-1","article-title":"Double-blind placebo controlled crossover study of prostacyclin in man","volume":"25","author":"Fitzgerald","year":"1979","journal-title":"Life Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1526-4610.1981.hed2105190.x","article-title":"Effect of infused prostacyclin in migraine and cluster headache","volume":"21","author":"Peatfield","year":"1981","journal-title":"Headache"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1468-2982.2009.01923.x","article-title":"Prostaglandin I(2) (epoprostenol) triggers migraine-like attacks in migraineurs","volume":"30","author":"Wienecke","year":"2010","journal-title":"Cephalalgia"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0304-3959(92)90058-J","article-title":"Acetylsalicylic-acid activates antinociceptive brain-stem reflex activity in headache patients and in healthy-subjects","volume":"48","author":"Gobel","year":"1992","journal-title":"Pain"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-3959(90)91111-U","article-title":"Central effect of the nonsteroid antiinflammatory agents, indomethacin, ibuprofen, and diclofenac, determined in c-fiber-evoked activity in single neurons of the rat thalamus","volume":"41","author":"Jurna","year":"1990","journal-title":"Pain"},{"key":"ref_58","first-page":"669","article-title":"The absorption of aspirin in migraine, and the effect of metoclopramide","volume":"10","author":"Rosslee","year":"1983","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2125.1975.tb00472.x","article-title":"Effect of metoclopramide on absorption of effervescent aspirin in migraine","volume":"2","author":"Volans","year":"1975","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00003495-199753010-00012","article-title":"Ketorolac\u2014A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management","volume":"53","author":"Gillis","year":"1997","journal-title":"Drugs"},{"key":"ref_61","first-page":"254","article-title":"Efficacy and tolerance of effervescent aspirin metoclopramide association in the treatment of migraine attack","volume":"24","author":"Henry","year":"1995","journal-title":"Presse Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2796.1992.tb00973.x","article-title":"Ketoprofen and ergotamine in acute migraine","volume":"231","author":"Kangasniemi","year":"1992","journal-title":"J. Inter. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-0404.1990.tb00996.x","article-title":"Randomized double-blind comparison of tolfenamic acid and paracetamol in migraine","volume":"81","author":"Larsen","year":"1990","journal-title":"Acta Neurol. Scand."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1468-2982.1991.1102059.x","article-title":"Effectiveness of oral diclofenac in the acute treatment of common migraine attacks\u2014A double-blind-study vs. placebo","volume":"11","author":"Massiou","year":"1991","journal-title":"Cephalalgia"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(95)91554-0","article-title":"The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine","volume":"346","author":"Tfelthansen","year":"1995","journal-title":"Lancet"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1468-2982.1999.019006581.x","article-title":"Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study","volume":"19","author":"Diener","year":"1999","journal-title":"Cephalalgia"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-2982.1984.0402107.x","article-title":"Effervescent metoclopramide and aspirin (Migravess) vs. effervescent aspirin or placebo for migraine attacks\u2014A double-blind-study","volume":"4","author":"Tfelthansen","year":"1984","journal-title":"Cephalalgia"},{"key":"ref_68","first-page":"663","article-title":"Acetylsalicylic acid effervescent 1000 mg (Aspirin (R)) in acute migraine attacks; a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study","volume":"20","author":"Lange","year":"2000","journal-title":"Cephalalgia"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1526-4610.2002.02076.x","article-title":"Mouth-dispersible aspirin in the treatment of migraine: A placebo-controlled study","volume":"42","author":"MacGregor","year":"2002","journal-title":"Headache"},{"key":"ref_70","first-page":"CD008041","article-title":"Aspirin with or without an antiemetic for acute migraine headaches in adults","volume":"4","author":"Kirthi","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1526-4610.1989.hed2908507.x","article-title":"Treatment of acute migraine attack\u2014Ibuprofen and placebo compared","volume":"29","author":"Havankakanniainen","year":"1989","journal-title":"Headache"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1468-2982.1992.1203169.x","article-title":"A double-blind-study of ibuprofen vs. placebo in the treatment of acute migraine attacks","volume":"12","author":"Kloster","year":"1992","journal-title":"Cephalalgia"},{"key":"ref_73","first-page":"145","article-title":"Effectiveness of ibuprofen-arginine in the treatment of acute migraine attacks","volume":"18","author":"Sandrini","year":"1998","journal-title":"Int. J. Clin. Pharm. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1468-2982.2000.00055.x","article-title":"Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: A randomized, double-blind, placebo-controlled, dose-ranging study","volume":"20","author":"Kellstein","year":"2000","journal-title":"Cephalalgia"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1526-4610.2001.041007665.x","article-title":"Efficacy of nonprescription doses of ibuprofen for treating migraine headache. A randomized controlled trial","volume":"41","author":"Codispoti","year":"2001","journal-title":"Headache"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10194-007-0386-7","article-title":"Rizatriptan vs. ibuprofen in migraine: A randomised placebo-controlled trial","volume":"8","author":"Misra","year":"2007","journal-title":"J. Headache Pain"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1468-2982.2004.00783.x","article-title":"Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks","volume":"24","author":"Diener","year":"2004","journal-title":"Cephalalgia"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1212\/WNL.48.1.103","article-title":"Ibuprofen or acetaminophen for the acute treatment of migraine in children: A double-blind, randomized, placebo-controlled, crossover study","volume":"48","author":"Hamalainen","year":"1997","journal-title":"Neurology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1526-4610.2002.02180.x","article-title":"Children's ibuprofen suspension for the acute treatment of pediatric migraine","volume":"42","author":"Lewis","year":"2002","journal-title":"Headache"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1001\/archinte.160.22.3486","article-title":"Efficacy and safety of acetaminophen in the treatment of migraine\u2014Results of a randomized, double-blind, placebo-controlled, population-based study","volume":"160","author":"Lipton","year":"2000","journal-title":"Arch. Inter. Med."},{"key":"ref_81","first-page":"388","article-title":"Double-blind controlled-study of paramax in the acute treatment of common and classical migraine","volume":"39","author":"Dexter","year":"1985","journal-title":"Br. J. Clin. Practice"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1468-2982.1994.1402156.x","article-title":"Double-blind comparison of an acetaminophen 400 mg codeine 25 mg combination vs. aspirin 1000 mg and placebo in acute migraine attack","volume":"14","author":"Boureau","year":"1994","journal-title":"Cephalalgia"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pain.2005.07.002","article-title":"Evaluation of the efficacy of intravenous acetaminophen in the treatment of acute migraine attacks: A double-blind, placebo-controlled parallel group multicenter study","volume":"117","author":"Leinisch","year":"2005","journal-title":"Pain"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(79)90343-X","article-title":"Tolfenamic acid is as effective as ergotamine during migraine attacks","volume":"2","author":"Hakkarainen","year":"1979","journal-title":"Lancet"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1526-4610.1998.3803201.x","article-title":"Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: Comparable effect in a double-blind, randomized, controlled, parallel-group study","volume":"38","author":"Myllyla","year":"1998","journal-title":"Headache"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1468-2982.1984.0404253.x","article-title":"Tolfenamic acid, metoclopramide, caffeine and their combinations in the treatment of migraine attacks","volume":"4","author":"Tokola","year":"1984","journal-title":"Cephalalgia"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1468-2982.1982.0204173.x","article-title":"Tolfenamic acid and caffeine\u2014A useful combination in migraine","volume":"2","author":"Hakkarainen","year":"1982","journal-title":"Cephalalgia"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1468-2982.1985.0502115.x","article-title":"Treatment of acute migraine attack\u2014Naproxen and placebo compared","volume":"5","author":"Nestvold","year":"1985","journal-title":"Cephalalgia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1468-2982.1989.901029.x","article-title":"Double-blind-study of naproxen vs. placebo in the treatment of acute migraine attacks","volume":"9","author":"Andersson","year":"1989","journal-title":"Cephalalgia"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1468-2982.1985.0501005.x","article-title":"Naproxen sodium in the treatment of migraine","volume":"5","author":"Johnson","year":"1985","journal-title":"Cephalalgia"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.297.13.1443","article-title":"Sumatriptan-naproxen for acute treatment of migraine: A randomized trial","volume":"297","author":"Brandes","year":"2007","journal-title":"JAMA"},{"key":"ref_92","first-page":"A265","article-title":"Assessing workplace productivity and activity time in migraineurs treated with a single-tablet of sumatriptan formulated with RT technology (TM) and naproxen sodium (SumaRT\/NAP) or placebo","volume":"68","author":"Landy","year":"2007","journal-title":"Neurology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1526-4610.2005.05178.x","article-title":"Sumatriptan and naproxen sodium for the acute treatment of migraine","volume":"45","author":"Smith","year":"2005","journal-title":"Headache"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1468-2982.1999.019004232.x","article-title":"Acute treatment of migraine attacks: Efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo","volume":"19","author":"Bussone","year":"1999","journal-title":"Cephalalgia"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1468-2982.1993.1302117.x","article-title":"Diclofenac-K (50 and 100 mg) and placebo in the acute treatment of migraine","volume":"13","author":"Dahlof","year":"1993","journal-title":"Cephalalgia"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2165\/00003495-199957060-00016","article-title":"Diclofenac-potassium in migraine\u2014A review","volume":"57","author":"McNeely","year":"1999","journal-title":"Drugs"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1526-4610.2004.04029.x","article-title":"Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: A randomized, double-blind, crossover study","volume":"44","author":"Peroutka","year":"2004","journal-title":"Headache"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/030006058701500105","article-title":"Intramuscular treatment of migraine attacks using diclofenac sodium\u2014A crossover clinical-trial","volume":"15","author":"Delbene","year":"1987","journal-title":"J. Inter. Med. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1468-2982.2008.01654.x","article-title":"Almotriptan and its combination with aceclofenac for migraine attacks: A study of efficacy and the influence of auto-evaluated brush allodynia","volume":"28","author":"Schoenen","year":"2008","journal-title":"Cephalalgia"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1468-2982.1988.0803175.x","article-title":"Placebo-controlled double-blind trial of pirprofen and an ergotamine tartrate compound in migraine attacks","volume":"8","author":"Kinnunen","year":"1988","journal-title":"Cephalalgia"},{"key":"ref_101","first-page":"492","article-title":"Efficacy of flurbiprofen in the treatment of acute migraine attacks\u2014A double-blind crossover study","volume":"32","author":"Awidi","year":"1982","journal-title":"Curr. Ther. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.58.11.1660","article-title":"Efficacy of oral ketoprofen in acute migraine\u2014A double-blind randomized clinical trial","volume":"58","author":"Dib","year":"2002","journal-title":"Neurology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1526-4610.1997.3701012.x","article-title":"Ketoprofen vs. paracetamol in the treatment of acute migraine","volume":"37","author":"Karabetsos","year":"1997","journal-title":"Headache"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/01.WNL.0000123260.61631.C4","article-title":"Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine","volume":"62","author":"Silberstein","year":"2004","journal-title":"Neurology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.1978.hed1801035.x","article-title":"Comparative trial of ergotamine tartrate, acetyl salicylic-acid and a dextropropoxyphene compound in acute migraine attacks","volume":"18","author":"Hakkarainen","year":"1978","journal-title":"Headache"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/j.1552-4604.1980.tb01674.x","article-title":"Mild analgesics as an alternative to ergotamine in migraine\u2014A comparative trial with acetylsalicylic-acid, ergotamine tartrate, and a dextropropoxyphene compound","volume":"20","author":"Hakkarainen","year":"1980","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000047959","article-title":"Zolmitriptan vs. a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: A double-blind, randomised, three-attack study","volume":"47","author":"Geraud","year":"2002","journal-title":"Eur. Neurol."},{"key":"ref_108","first-page":"465","article-title":"Ibuprofen compared with paracetamol in migraine","volume":"227","author":"Pearce","year":"1983","journal-title":"Practitioner"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1526-4610.1992.hed3202098.x","article-title":"Treatment of acute migraine attack with diclofenac sodium\u2014A double-blind-study","volume":"32","author":"Karachalios","year":"1992","journal-title":"Headache"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1468-2982.1983.0302129.x","article-title":"Double-blind comparison of mefenamic-acid and acetaminophen (Paracetamol) in migraine","volume":"3","author":"Peatfield","year":"1983","journal-title":"Cephalalgia"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-2982.1985.0502107.x","article-title":"Acute migraine attack therapy\u2014Comparison of naproxen sodium and an ergotamine tartrate compound","volume":"5","author":"Pradalier","year":"1985","journal-title":"Cephalalgia"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1526-4610.1992.hed3206280.x","article-title":"Naproxen sodium vs. ergotamine tartrate in the treatment of acute migraine attacks","volume":"32","author":"Treves","year":"1992","journal-title":"Headache"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1526-4610.1988.hed2804263.x","article-title":"Aborting a migraine attack\u2014Naproxen sodium v ergotamine plus caffeine","volume":"28","author":"Sargent","year":"1988","journal-title":"Headache"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0196-0644(05)82928-2","article-title":"A randomized, double-blind, comparative-study of the efficacy of ketorolac tromethamine vs. meperidine in the treatment of severe migraine","volume":"21","author":"Larkin","year":"1992","journal-title":"Ann. Emerg. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0735-6757(95)90081-0","article-title":"Ketorolac vs. meperidine-plus-promethazine treatment of migraine headache\u2014Evaluations by patients","volume":"13","author":"Davis","year":"1995","journal-title":"Amer. J. Emerg. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1001\/archinte.1996.00440140163017","article-title":"Ketorolac vs. chlorpromazine in the treatment of acute migraine without aura\u2014A prospective, randomized, double-blind trial","volume":"156","author":"Shrestha","year":"1996","journal-title":"Arch. Intern. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1553-2712.1998.tb02463.x","article-title":"Intravenous ketorolac vs. intravenous prochlorperazine for the treatment of migraine headaches","volume":"5","author":"Seim","year":"1998","journal-title":"Acad. Emerg. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0735-6757(02)42256-5","article-title":"A prospective double-blind study of nasal sumatriptan vs. IV ketorolac in migraine","volume":"21","author":"Meredith","year":"2003","journal-title":"Amer. J. Emerg. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1742-1241.2007.01458.x","article-title":"Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: A double-blind, double-dummy, randomised, parallel group, multicentre study","volume":"61","author":"Sandrini","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1526-4610.2003.03161.x","article-title":"Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: A multicenter, randomized, crossover trial","volume":"43","author":"Nicolodi","year":"2003","journal-title":"Headache"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/gut.2005.080754","article-title":"Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations","volume":"55","author":"Lanas","year":"2006","journal-title":"Gut"},{"key":"ref_122","first-page":"A95","article-title":"Coxibs, NSAIDs, aspirin, PPIs and the risks of upper GI bleeding in common clinical practice","volume":"128","author":"Lanas","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1526-4610.1988.hed2808550.x","article-title":"Treatment review\u2014Non-steroid anti-inflammatory drugs in the treatment and long-term prevention of migraine attacks","volume":"28","author":"Pradalier","year":"1988","journal-title":"Headache"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR study group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/hc4401.100078","article-title":"Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib","volume":"104","author":"Konstam","year":"2001","journal-title":"Circulation"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.amjcard.2009.01.014","article-title":"An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs","volume":"103","author":"Farkouh","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","article-title":"Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study","volume":"48","author":"Bigal","year":"2008","journal-title":"Headache"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00019052-200406000-00011","article-title":"Medication overuse headache","volume":"17","author":"Limmroth","year":"2004","journal-title":"Curr. Opin. Neurol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1526-4610.1981.hed2106240.x","article-title":"Tolfenamic acid and ergotamine abuse","volume":"21","author":"Alahurula","year":"1981","journal-title":"Headache"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1526-4610.1987.hed2703130.x","article-title":"Amelioration of ergotamine withdrawal symptoms with naproxen","volume":"27","author":"Mathew","year":"1987","journal-title":"Headache"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/3\/6\/1966\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:02:43Z","timestamp":1760220163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/3\/6\/1966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,17]]},"references-count":130,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2010,6]]}},"alternative-id":["ph3061966"],"URL":"https:\/\/doi.org\/10.3390\/ph3061966","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,17]]}}}